Role of Novel Biological Therapies in Psoriatic Arthritis: Effects on Joints and Skin

ISSN： 1173-8804

Source： BioDrugs, Vol.17, Iss.3, 2003-01, pp. : 187-199

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Psoriatic Arthritis: Recognition and Management

By Bruce I.N. Gladman D.D.

BioDrugs, Vol. 9, Iss. 4, 1998-04 ,pp. : 271-278

Adis International

Access to resources Recommend Favorite

Immunomodulating Drugs in the Management of Psoriatic Arthritis

By Jackson C.G.

American Journal of Clinical Dermatology, Vol. 2, Iss. 6, 2001-06 ,pp. : 367-375

Adis International

Access to resources Recommend Favorite

Spotlight on Etanercept in Plaque Psoriasis and Psoriatic Arthritis

By Goldsmith David R. Wagstaff Antona J.

BioDrugs, Vol. 19, Iss. 6, 2005-01 ,pp. : 401-403

Adis International

Access to resources Recommend Favorite

TNF Inhibitors in the Treatment of Psoriasis and Psoriatic Arthritis

By Tobin Anne-Marie Kirby Brian

BioDrugs, Vol. 19, Iss. 1, 2005-01 ,pp. : 47-57

Adis International

Access to resources Recommend Favorite

Golimumab: In the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis

By Oldfield Vicki Plosker Greg L.

BioDrugs, Vol. 23, Iss. 2, 2009-06 ,pp. : 125-135

Adis International

Access to resources Recommend Favorite